A carregar...
Randomized, Controlled Trial of TRC101 to Increase Serum Bicarbonate in Patients with CKD
BACKGROUND AND OBJECTIVES: Metabolic acidosis is common in patients with CKD and has significant adverse effects on kidney, muscle, and bone. We tested the efficacy and safety of TRC101, a novel, sodium-free, nonabsorbed hydrochloric acid binder, to increase serum bicarbonate in patients with CKD an...
Na minha lista:
| Publicado no: | Clin J Am Soc Nephrol |
|---|---|
| Main Authors: | , , , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
American Society of Nephrology
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5753317/ https://ncbi.nlm.nih.gov/pubmed/29102959 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2215/CJN.07300717 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|